Blog
For Release Immediately
December 31st, 2012
DES PLAINES, IL— HairStat® / NailStat®Improved Cutoffs — Today, United States Drug Testing Laboratories, Inc. announced that they will introduce lower substances of abuse screening and confirmation cutoffs for hair and nail specimens.
Positive Customer Impact
Many customers have already benefited from using USDTL as a laboratory that can customize drug testing to suit their needs. The improvement of the cutoffs means that customers can now have a wider range of detection for certain substances of abuse, and can be assured that they are receiving positive drug screen confirmations not currently available at market place. The breadth and sensitivity of the profiles make these tests more effective.
HairStat® / NailStat® Availability
These improvements in HairStat and NailStat are driven by USDTL’s ongoing commitment to be a leader in alcohol and substances of abuse detection. These cutoffs will be effective for hair and nail specimens received at USDTL on or after January 2nd, 2013.
Established in 1991 as a specialty drug testing facility, United States Drug Testing Laboratories, Inc. quickly became a leader in the industry. They have made significant breakthroughs by developing procedures to effectively use specimens to diagnose alcohol and substance misuse and abuse. They offer a wide range of testing services and specialize in hard to detect substances of abuse and customized assays.
For more information please visit http://www.USDTL.com
###
USDTL, HairStat®, NailStat® are trademarks of Unites States Drug Testing Laboratories, Inc. in the United States and/or other countries.
For more information on HairStat® or NailStat®:
- Umbilical Cord Tissue Testing for SSRIs
- A Comparison of Turnaround-Times for Two Popular Specimen Types Used for Newborn Toxicology: Meconium and Umbilical Cord Tissue
- Using Umbilical Cord Tissue to Identify Prenatal Ethanol Exposure and Co-exposure to Other Commonly Misused Substances
- Toxicology as a Diagnostic Tool to Identify the Misuse of Drugs in the Perinatal Period
- Specimen Delay
- Drug Classes and Neurotransmitters: Amphetamine, Cocaine, and Hallucinogens
- Environmental Exposure Testing for Delta-8 THC, Delta-9 THC, Delta-10 THC, and CBD
- Bromazolam and Synthetic Benzodiazepines
- October 2024 (5)
- March 2024 (1)
- February 2024 (1)
- January 2024 (3)
- December 2023 (1)
- November 2023 (1)